1 – 10 of 49
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
Two consecutive randomized controlled pertussis booster trials in children initially vaccinated in infancy with an acellular vaccine: The first with a five-component Tdap vaccine to 5-year olds and the second with five- or monocomponent Tdap vaccines at age 14-15 years.
(
- Contribution to journal › Article
- 2014
-
Mark
Impact of immunization with Protein F on pulmonary clearance of nontypeable Haemophilus influenzae.
(
- Contribution to journal › Article
-
Mark
Parental attitudes and decision-making regarding MMR vaccination in an anthroposophic community in Sweden – A qualitative study
(
- Contribution to journal › Article
- 2013
-
Mark
Pre-vaccination seroprevalence of 15 human papillomavirus (HPV) types among women in the population-based Slovenian cervical screening program
(
- Contribution to journal › Article
-
Mark
The immunological effect of revaccination with Bacille Calmette-Guerin vaccine at 19 months of age
(
- Contribution to journal › Article
-
Mark
13-Valent pneumococcal conjugate vaccine (PCV13) in children partially immunized with 7-valent pneumococcal conjugate vaccine (PCV7): A phase 3, open-label trial
(
- Contribution to journal › Article
- 2012
-
Mark
A tetravalent meningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine is immunogenic and well-tolerated when co-administered with Twinrix (R) in subjects aged 11-17 years: An open, randomised, controlled trial
(
- Contribution to journal › Article
-
Mark
International collaborative proficiency study of Human Papillomavirus type 16 serology.
(
- Contribution to journal › Article
- 2011
-
Mark
The factor H-binding fragment of PspC as a vaccine antigen for the induction of protective humoral immunity against experimental pneumococcal sepsis
(
- Contribution to journal › Article
-
Mark
Prevalence of antibodies against Kaposi's sarcoma associated herpes virus (KSHV) complement inhibitory protein (KCP) in KSHV-related diseases and their correlation with clinical parameters.
(
- Contribution to journal › Article